Evidence, value and access consulting
We provide technical consulting and expertise across the product journey, helping our clients maximize the value of their available evidence and addressing gaps to support successful access and reimbursement strategies within their target markets.
Our team consists of technical experts including health economists, statisticians, medical writers, in-house graphic designers, commercial assessment analysts, systematic reviewers, and COA specialists, enabling us to provide bespoke, end-to-end solutions across the product lifecycle with the goal of optimizing market access.
Clinical outcomes assessment
Our experts can streamline your clinical development strategy with fit-for-purpose PROs and other COA instruments to support regulatory, communication, and reimbursement strategies.
Offerings include:
- COA reviews (targeted literature reviews and gap analysis)
- COA development
- COA content validation
- COA interpretation
- COA regulatory support
- COA training
- Preference studies
- Utility studies
- COA general consultancy (e.g., clinical trial protocol reviews)
- COA publication/dissemination
Health economics
We design, construct, data populate, test and adapt economic models to demonstrate product value and increase likelihood of positive funding decisions in your target markets.
Offerings include:
- Early analysis and economic modeling
- Multi-country adaptation support
- Evidence generation strategy
- Post-launch economic tool development (e.g., iPad-based BIMs)
- Consultancy and training (economic evidence generation strategy, mentorship of internal modeling teams)
- Clinical trial data analysis
- Real-world data analysis
- Publications
Health technology assessment (HTA)
Clarivate can develop, coordinate and deliver a robust HTA strategy to effectively convey the benefit of your asset for favorable reimbursement outcomes in target markets.
Offerings include:
- HTA strategy development and support
- HTA dossier development
- HTA model and SLR development, critique and adaptation
- Early HTA/scientific advice
- Customized submissions
- Mock committee meetings
Evidence generation
Clarivate can develop robust, reproducible, high quality systematic literature reviews and indirect treatment comparisons to support HTA submissions and Market Access activities. Our offerings include:
- Systematic literature reviews
- HTA submissions
- Economic models
- Product development
- Market access strategy
- Targeted literature reviews
- Value message development
- Core value dossiers
- Global and local market access activities
- Directing future research and evidence generation
- Statistical analyses
- Feasibility assessments
- Pair-wise meta-analysis
- Indirect treatment comparisons
- Network meta-analyses
- Consultancy and training
Biopharma customer engagement solution
Uncover and truly understand customer perceptions, needs and behaviors so you can effectively engage with physicians, patients and payers.
Customer engagement
Our latest thought leadership
Let's get real about data and AI
Bringing the patient voice into clinical trials with clinical outcome assessments
Clinical outcome assessments can take years to generate but may pay big dividends in patient-focused drug development, centering the patient experience and potentially bolstering a product’s case with regulators and…
